Needs in Education for Pulmonary or Cardiopulmonary Transplanted Cystic Fibrosis Patients

Cystic Fibrosis Clinical Trial

Official title:

Assessing of the Educational Needs of Patients Who Received a Lung Transplantation or a Simultaneous Heart-lung Transplantation for Mucoviscidosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01285895
• Other study ID #: PROG/10/90
• Status: Completed
• Phase: N/A
• First received: January 27, 2011
• Last updated: April 14, 2015
• Start date: September 2009
• Est. completion date: October 2013

Study information

• Verified date: April 2015
• Source: Nantes University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Institutional Ethical Committee
• Study type: Observational

Clinical Trial Summary

Main objective : This project aims to assess the educational needs of patients who received a lung transplantation or a simultaneous heart-lung transplantation for mucoviscidosis.

Specific objectives : Evaluate the specific needs dependent on seniority transplantation : 3 to 6 months, 6 months to 2 years, more than 2 years after transplantation

Secondary objectives :

• Assess the state of health

• Assess the knowledge

• Assess gestural know-how

• Assess the cognitive know-how

• Assess the behaviour adopted in reality by the patient

• Assess motivation psychosocial factors of :

• self-efficacy and inefficiency

• representation of obstacles, disadvantages of treatment

• sense of control over their health

• feeling of being supported by health professionals, by his close

• representation of his responsibility to take care of his health, to follow his treatment, to be active about his treatment

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: October 2013
• Est. primary completion date: October 2013
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients who received a lung transplantation or a simultaneous heart-lung transplantation for mucoviscidosis

Exclusion Criteria:

• Patient with a psychiatric disorder

• Patient in intensive care

• Palliative patient

• Patient aged under 18 years old

• Patient refusal

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Cystic Fibrosis
• Fibrosis

Locations

Country	Name	City	State
France	Nantes University Hospital	Nantes

Sponsors (1)

Lead Sponsor	Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France,